qPCR, also known as real-time PCR, allows users to monitor the progress of a PCR in real time. Employing qPCR allows professionals to calculate PCR amplification simultaneously as the reaction proceeds. qPCR is an extensively used diagnostic technique in diverse sectors such as research, pharmaceuticals, and biotechnology. The demand for molecular testing is fueled by technological advancements in PCR systems, and the need for accurate and reliable cancer biomarker detection processes. Technological advancements in qPCR technologies and the growing demand for qPCR in infectious disease diagnosis are further projected to propel the growth of the market in the coming years. The quantitative PCR (qPCR) market trends include the integration of artificial intelligence and data analysis.
PCR has become a crucial tool for various clinical and diagnostic applications or examinations. Relative simplicity, exquisite sensitivity, and cost-effectiveness are among the noteworthy advantages of PCR that have tremendously increased the use of PCR technology in the past years. It is a robust and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and single nucleotide variation analysis. It also serves as the basis for most next-generation sequencing (NGS) preparation. Technological advancements are producing different types of PCR techniques. In particular, high-tech real-time PCR or qPCR systems are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Since its development, qPCR has grown to be an essential component of molecular biology and is widely used in research, clinical diagnostics, and testing for food safety. Its major advantages are rooted in the quantification and viral strain genotyping abilities it offers to users, enabling the estimation of reinfection based on the quantity of virus present in target tissues. It has transformed the field of nucleic acid detection and quantification, allowing researchers and medical professionals to analyze genes, mutations, and genetic variants in unprecedented detail.
CRISPR-based qPCR, automated qPCR systems, multiplex qPCR, and next-generation qPCR are examples of recent advancements in qPCR technology. With improved sensitivity, specificity, and accuracy, these systems broaden the application of qPCR in clinical diagnosis, research, and food safety testing, among other applications. Multiple target sequences can be detected and quantified in a single reaction using multiplex qPCR, saving time and reducing sample requirements. This method is useful for pathogen detection, gene expression profiling, and genetic variation analysis. In addition, next-generation qPCR helps detect and quantify nucleic acid sequences in an array of samples using cutting-edge sequencing technologies. This technique has a high degree of sensitivity and accuracy for detecting low-abundance target sequences. With careful consideration of primer design, optimization, and sample preparation, qPCR analysis can yield valuable insights into gene expression, disease diagnosis, and food safety testing. Thus, technological advancements in PCR technologies are contributing to the quantitative PCR (qPCR) market growth.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Quantitative PCR (qPCR) Market: Strategic Insights
The quantitative PCR (qPCR) market analysis has been carried out by considering the following segments: type, product, application, end user, and geography. Based on type, the market is segmented into one-step qPCR and two-step qPCR. In terms of product, the market is classified into reagents and consumables, instruments, and software and services. By application, the market is segmented into research, clinical, and forensics. Based on end user, the market is categorized into hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, forensic laboratories, and clinical research organizations. The geographic scope of the quantitative PCR (qPCR) market report covers North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
The quantitative PCR (qPCR) market, by type, is categorized into one-step qPCR and two-step qPCR. The two-step qPCR segment held a significant market share in 2023. It is anticipated to record a higher CAGR in the market during 2023–2031.
Based on product, the market is categorized into reagents and consumables, instruments, and software and services. The reagents and consumables segment held a significant quantitative PCR (qPCR) market share in 2023, and it is further estimated to register the highest CAGR during 2023–2031.
The quantitative PCR (qPCR) market, by application, is categorized into research, clinical, and forensics. The clinical segment held a significant market share in 2023. It is anticipated to record the highest CAGR in the market during 2023–2031.
Based on end user, the quantitative PCR (qPCR) market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held a significant market share in 2023 and is expected to register the highest CAGR during 2023–2031.
In terms of geography, the quantitative PCR (qPCR) market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2023, North America captured a significant share of the market. In 2023, the US dominated the market in this region. The quantitative PCR (qPCR) market growth in North America is attributed to the extensive R&D conducted across various academic and research institutes, growing focus on employing advanced techniques and tools in healthcare, government and private initiatives and funds for promoting precision medicine as well as genomic research, upsurge in demand for innovative products from PCR companies, and presence of key market players.
In June 2020, Azure Biosystems launched Azure Cielo real-time PCR instrument. The Cielo is a 96-well qPCR machine that maintains the brand promise of compact design, high performance, and intuitive workflow. The Azure Biosystem's sensitivity and reliability have been devoted to genomics applications. The Cielo marks the first instrument dedicated to the genomics workflow for the company.
The quantitative PCR (qPCR) market report includes company positioning and concentration to evaluate the performance of competitors in the market. As per company press releases, below are a few initiatives taken by key players operating in the market:
The regional trends and factors influencing the Quantitative PCR (qPCR) Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Quantitative PCR (qPCR) Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 2.57 Billion |
| Market Size by 2031 | US$ 4.82 Billion |
| Global CAGR (2023 - 2031) | 8.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Quantitative PCR (qPCR) Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Quantitative PCR (qPCR) Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The quantitative PCR (qPCR) market forecast can help stakeholders plan their growth strategies. Abbott Laboratories, Thermo Fisher Scientific Inc., Standard Biotools Inc., F. Hoffmann-la Roche Ltd, Qiagen, Lepu Medical Technology Beijing Co Ltd, Bio-rad Laboratories Inc., Takara Bio Inc., Agilent Technologies Inc., and Fujirebio are among the prominent players profiled in the market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.
The List of Companies - Quantitative PCR (qPCR) Market
Quantitative PCR (qPCR) quantifies the process of PCR amplification as the reaction proceeds. It is an extensively used diagnostic technique in diverse sectors such as research, pharmaceuticals, and biotechnology, offering a wide range of applications. Numerous research institutions and universities provide excellent assistance by providing qPCR platforms for doing various tests, one of the most accurate laboratory methods for identifying, tracking, and investigating the COVID-19 virus.
The quantitative PCR (qPCR) market majorly consists of the players, including Abbott Laboratories, Thermo Fisher Scientific Inc., Standard Biotools Inc., F. Hoffmann-la Roche Ltd, Qiagen, Lepu Medical Technology Beijing Co Ltd, Bio-rad Laboratories Inc., Takara Bio Inc., Agilent Technologies Inc., and Fujirebio.
The factors driving the growth of the quantitative PCR (qPCR) market include the advancements in qPCR and the rising demand for qPCR systems in infectious disease detection. However, the high cost of real-time PCR systems hampers the growth of the quantitative PCR (qPCR) market.
The quantitative PCR (qPCR) market is expected to be valued at US$ 4.82 billion in 2031.
The global quantitative PCR (qPCR) market is segmented based on type, product, application, and end user. The quantitative PCR (qPCR) market, by type, is categorized into one-step qPCR and two-step qPCR. The two-step qPCR segment held a significant market share in 2023 and is anticipated to record the highest CAGR in the market during 2023–2031.
The quantitative PCR (qPCR) market was valued at US$ 2.57 billion in 2023.